Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1641 1677 1678
This examiner grants 42% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17671927 | LATEX AGGLUTINATION REACTION SENSITIZER, LATEX AGGLUTINATION REAGENT, AND METHOD FOR MEASURING TARGET SUBSTANCE IN SPECIMEN BY LATEX AGGLUTINATION METHOD USING THE SAME | Non-Final OA | CANON MEDICAL SYSTEMS CORPORATION |
| 18185624 | METHODS AND SYSTEMS FOR ANALYZING POLYPEPTIDE VARIANTS | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18686824 | MULTIPLEXED PROTEOMICS ANALYSIS USING OLIGONUCLEOTIDE-CONJUGATED ANTIBODIES | Non-Final OA | Becton, Dickinson and Company |
| 18645358 | ON-BOARD CONJUGATION | Non-Final OA | Roche Diagnostics Operations, Inc. |
| 18490562 | PROTEIN CAPTURE FROM RAW CELL CULTURE USING PROTEIN A AFFIXED IN OPEN TUBULAR AND ANNULAR HELICALLY COILED TUBES | Non-Final OA | Waters Technologies Corporation |
| 17350822 | METHODS FOR DETECTING AN ANALYTE USING STRUCTURE SWITCHING BINDING AGENTS | Final Rejection | Roche Sequencing Solutions, Inc. |
| 17574169 | Method of Detecting the Presence of an Analyte in a Sample | Non-Final OA | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 18340625 | DEVICE FOR TESTING MULTIPLE ANALYTES IN LIQUID SAMPLE THROUGH LATERAL FLOW | Final Rejection | Zhejiang Orient Gene Biotech Co.,Ltd |
| 17576183 | Detecting Apparatus | Non-Final OA | Zhejiang Orient Gene Biotech Co., Ltd |
| 18319302 | ASSAY SYSTEM FOR MULTIPLE ANALYTES | Non-Final OA | UniQ Biotech Ltd. |
| 18428273 | Assays For Determining Severity Of Peanut Allergies | Non-Final OA | AllerGenis, Inc. |
| 17630757 | BITTER TASTE RECEPTOR BLOCKERS AND METHODS OF THEIR IDENTIFICATION | Non-Final OA | Firmenich Incorporated |
| 18286027 | HER2 VACCINE COMPOSITION | Non-Final OA | ASTON SCI. INC. |
| 17567555 | REDUCING OPTICAL INTERFERENCE IN A FLUIDIC DEVICE | Final Rejection | Labrador Diagnostics LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy